Virpax Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Virpax Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Virpax Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 4.66M shares, a 298% increase year-over-year.
  • Virpax Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.17M shares, a 0.02% increase from 2022.
  • Virpax Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.17M shares, a 82.5% decline from 2021.
  • Virpax Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 6.68M shares, a 115% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 4.66M +3.49M +298% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.98M +806K +68.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 1.17M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 1.17M +213 +0.02% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 1.17M -10.5M -90% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 1.17M -10.5M -90% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 1.17M -10.5M -90% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 1.17M -5.51M -82.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 11.7M +5.7M +94.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-07
Q2 2022 11.7M +6.75M +136% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 11.7M +7.76M +197% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 6.68M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 6.01M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 4.96M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 3.95M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.